MetaVia Inc. (MTVA): Total Liabilities
$5.79M
As of 2025-12-31
$6.45M
As of 2026-06-30
-21.1%
3-year compound annual growth
+9.0%
5-year compound annual growth
-4.2%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.79M | -30.5% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $8.33M | +36.6% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $6.10M | -48.3% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $11.78M | +435.1% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $2.20M | -41.5% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $3.77M | +73.0% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $2.18M | +504.4% | 2021-04-15, Balance as of period end |
| 2018-12-31 | $360.0K | -97.6% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $15.08M | +265.7% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $4.12M | -53.8% | 2018-03-20, Balance as of period end |
| 2015-12-31 | $8.92M | n/a | 2017-03-21, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| MetaVia Inc. (MTVA) | 2025-12-31 | $5.79M | -30.5% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $702.1K | -2.9% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $5.17M | +241.9% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $4.50M | +2.7% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $4.20M | -52.9% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $361.0K | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $2.72M | +42.2% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $11.25M | -80.1% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $8.22M | +357.5% |
Compare MTVA, MIRA, DCOY, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗